Azenta, Inc. (AZTA)
NASDAQ: AZTA · Real-Time Price · USD
35.05
-0.05 (-0.14%)
At close: Dec 5, 2025, 4:00 PM EST
34.37
-0.68 (-1.94%)
After-hours: Dec 5, 2025, 5:03 PM EST
Azenta Market Cap
Azenta has a market cap or net worth of $1.61 billion as of December 5, 2025. Its market cap has decreased by -19.45% in one year.
Market Cap
1.61B
Enterprise Value
1.13B
1-Year Change
-19.45%
Ranking
Category
Stock Price
$35.05
Market Cap Chart
Since December 1, 1998, Azenta's market cap has increased from $156.00M to $1.61B, an increase of 933.28%. That is a compound annual growth rate of 9.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.60B | -41.66% |
| Dec 31, 2024 | 2.75B | -38.94% |
| Dec 29, 2023 | 4.50B | 3.18% |
| Dec 30, 2022 | 4.37B | -43.01% |
| Dec 31, 2021 | 7.66B | 53.08% |
| Dec 31, 2020 | 5.00B | 65.34% |
| Dec 31, 2019 | 3.03B | 63.89% |
| Dec 31, 2018 | 1.85B | 11.18% |
| Dec 29, 2017 | 1.66B | 41.81% |
| Dec 30, 2016 | 1.17B | 62.52% |
| Dec 31, 2015 | 720.70M | -15.39% |
| Dec 31, 2014 | 851.80M | 22.12% |
| Dec 31, 2013 | 697.50M | 30.67% |
| Dec 31, 2012 | 533.80M | -21.43% |
| Dec 30, 2011 | 679.40M | 15.25% |
| Dec 31, 2010 | 589.50M | 6.85% |
| Dec 31, 2009 | 551.70M | 49.51% |
| Dec 31, 2008 | 369.00M | -63.14% |
| Dec 31, 2007 | 1.00B | -7.76% |
| Dec 29, 2006 | 1.09B | 91.38% |
| Dec 30, 2005 | 567.10M | -26.06% |
| Dec 31, 2004 | 767.00M | -13.40% |
| Dec 31, 2003 | 885.70M | 112.40% |
| Dec 31, 2002 | 417.00M | -48.51% |
| Dec 31, 2001 | 809.90M | 67.58% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |